Replies to post #93091 on Anavex Life Sciences Corp (AVXL)

[OFP]

The Neurology Review article suited me much better. The insiders in this field have a better grasp of our compound's potential.

You should be aware of the source for the Neurology Review Article...it was written by a reporter based on the CTAD presentation. It would be based solely on AVXL's presentation without any kind of non-AVXL "insider" input.